Based on established relationships between β-CATENIN and NANOG-downstream gene YAP1 in upregulating BIRC5 (37, 38), we evaluated relationships between BIRC5, β-CATENIN, and NANOG expression levels with poor HCC prognosis or malignant transformation of HCC development. The gene discussed is BIRC5; the disease is hepatocellular carcinoma.